Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-09-20

FDA Approved: INVOKAMET XR — Original Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved INVOKAMET XR (canagliflozin and metformin hydrochloride) through an Original Application. It is indicated for the treatment of type 2 diabetes mell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INVOKAMET XR (CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE)

Snippet

ORIG AP for INVOKAMET XR (CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE)